Health Economic Evaluation of Proton Therapy for Lung Cancer: A Systematic Review.
Chia-Chin LiYing-Chun LinJi-An LiangKun-San Clifford ChaoTe-Chun HsiaChun-Ru ChienPublished in: International journal of environmental research and public health (2023)
Passively scattered proton therapy was more costly and not cost-effective than photon therapy for early- and locally advanced-stage non-small cell lung cancer. Further health economic evaluations regarding modern proton therapy (such as scanning beam) for common radiotherapy indications of lung cancer are eagerly awaited.
Keyphrases
- locally advanced
- healthcare
- public health
- mental health
- rectal cancer
- squamous cell carcinoma
- neoadjuvant chemotherapy
- radiation therapy
- early stage
- health information
- electron microscopy
- high resolution
- phase ii study
- radiation induced
- health promotion
- clinical trial
- human health
- living cells
- risk assessment
- open label
- study protocol